25.14
0.95%
-0.24
Celldex Therapeutics Inc (CLDX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
96.22%
0.156
|
4.131 | 1.517 | 0.268 | 0.967 |
Operating Expenses
|
20.78%
40.76
|
51.46 | 42.76 | 33.47 | 33.44 |
Benefits Costs and Expenses |
5.48%
40.76
|
38.65 | 42.76 | 33.47 | 33.44 |
Costs And Expenses |
21.24%
40.76
|
51.76 | 42.76 | 33.47 | 33.44 |
Operating Income/Loss |
14.74%
-40.61
|
-47.63 | -41.24 | -33.20 | -32.47 |
Income/Loss From Continuing Operations Before Tax |
17.66%
-40.61
|
-34.51 | -41.24 | -30.50 | -29.36 |
Income/Loss From Continuing Operations After Tax |
353.21%
-32.81
|
-7.239 | -38.26 | -30.50 | -29.36 |
Net Income/Loss
|
24.24%
-32.81
|
-43.31 | -38.26 | -30.50 | -29.36 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
4,782%
0.0589
|
0.00121 | 0.0473 | 0.0473 | 0.0472 |
Diluted Average Shares |
4,782%
0.0589
|
0.00121 | 0.0473 | 0.0473 | 0.0472 |
Basic Earnings Per Share |
33.33%
-0.56
|
-0.84 | -0.81 | -0.65 | -0.62 |
Diluted Earnings Per Share |
33.33%
-0.56
|
-0.84 | -0.81 | -0.65 | -0.62 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):